source
- OKYO Pharma CSO Raj Patil boosts stake to 20,030 sharesOKYO Pharma, a clinical stage biotech focused on neuropathic corneal pain and anterior segment eye diseases, disclosed that its chief scientific officer, Raj Patil, PhD, bought additional shares.…
- Danske Bank reports share sell-off by APMH Invest under ongoing buy-back programDanske Bank A/S disclosed recent transactions made by persons required to report under the EU Market Abuse Regulation. The notification dated 28 July 2026 notes that APMH Invest A/S has been conti…